{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:15:49Z","timestamp":1780668949744,"version":"3.54.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-68443-2","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T14:12:46Z","timestamp":1722262366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Computational approach for drug discovery against Gardnerella vaginalis in quest for safer and effective treatments for bacterial vaginosis"],"prefix":"10.1038","volume":"14","author":[{"given":"Chenyue","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarrin","family":"Basharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karmen","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin R.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"68443_CR1","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.2147\/IDR.S305329","volume":"5","author":"A Bitew","year":"2021","unstructured":"Bitew, A., Mengist, A., Belew, H., Aschale, Y. & Reta, A. The prevalence, antibiotic resistance pattern, and associated factors of bacterial vaginosis among women of the reproductive age group from felege hiwot referral hospital, Ethiopia. Infect. Drug Resist. 5, 2685\u20132696 (2021).","journal-title":"Infect. Drug Resist."},{"key":"68443_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.resmic.2017.02.011","volume":"168","author":"JJ Schellenberg","year":"2017","unstructured":"Schellenberg, J. J., Patterson, M. H. & Hill, J. E. Gardnerella vaginalis diversity and ecology in relation to vaginal symptoms. Res. Microbiol. 168, 837\u2013844 (2017).","journal-title":"Res. Microbiol."},{"key":"68443_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.858155","volume":"12","author":"H Qin","year":"2022","unstructured":"Qin, H. & Xiao, B. Research progress on the correlation between Gardnerella typing and bacterial vaginosis. Front. Cell. Infect. Microbiol. 12, 858155 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"68443_CR4","doi-asserted-by":"publisher","first-page":"1033040","DOI":"10.3389\/fmicb.2022.1033040","volume":"13","author":"X Ma","year":"2022","unstructured":"Ma, X. et al. Biofilm and pathogenic factor analysis of Gardnerella vaginalis associated with bacterial vaginosis in Northeast China. Front. Microbiol. 13, 1033040 (2022).","journal-title":"Front. Microbiol."},{"key":"68443_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06562-1","volume":"21","author":"R Bhujel","year":"2021","unstructured":"Bhujel, R., Mishra, S. K., Yadav, S. K., Bista, K. D. & Parajuli, K. Comparative study of Amsel\u2019s criteria and Nugent scoring for diagnosis of bacterial vaginosis in a tertiary care hospital, Nepal. BMC Infect. Dis. 21, 1\u20136 (2021).","journal-title":"BMC Infect. Dis."},{"key":"68443_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.2298\/VSP140612065N","volume":"72","author":"DB Nenadi\u0107","year":"2015","unstructured":"Nenadi\u0107, D. B., Pavlovi\u0107, M. D. & Motrenko, T. A novel microscopic method for analyzing Gram-stained vaginal smears in the diagnosis of disorders of vaginal microflora. Vojnosanit. Pregl. 72, 670\u2013676 (2015).","journal-title":"Vojnosanit. Pregl."},{"key":"68443_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.17305\/bjbms.2008.2932","volume":"8","author":"F Numanovi\u0107","year":"2008","unstructured":"Numanovi\u0107, F. et al. Importance of isolation and biotypization of Gardnerella vaginalis in diagnosis of bacterial vaginosis. Bosn. J. Basic Med. Sci. 8, 270 (2008).","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"68443_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fcimb.2020.00354","volume":"10","author":"MJ Redelinghuys","year":"2020","unstructured":"Redelinghuys, M. J., Geldenhuys, J., Jung, H. & Kock, M. M. J. Bacterial vaginosis: Current diagnostic avenues and future opportunities. Front. Cell. Infect. Microbiol. 10, 354 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"68443_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2501-y","volume":"17","author":"M Janulaitiene","year":"2017","unstructured":"Janulaitiene, M. et al. Prevalence and distribution of Gardnerella vaginalis subgroups in women with and without bacterial vaginosis. BMC Infect. Dis. 17, 1\u20139 (2017).","journal-title":"BMC Infect. Dis."},{"key":"68443_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3389\/fcimb.2019.00452","volume":"9","author":"M Pleckaityte","year":"2020","unstructured":"Pleckaityte, M. Cholesterol-dependent cytolysins produced by vaginal bacteria: Certainties and controversies. Front. Cell. Infect. Microbiol. 9, 452 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"68443_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172522","volume":"12","author":"L Hardy","year":"2017","unstructured":"Hardy, L. et al. The presence of the putative Gardnerella vaginalis sialidase A gene in vaginal specimens is associated with bacterial vaginosis biofilm. PLoS ONE 12, e0172522 (2017).","journal-title":"PLoS ONE"},{"key":"68443_CR12","doi-asserted-by":"publisher","first-page":"1100029","DOI":"10.3389\/frph.2023.1100029","volume":"5","author":"C Abbe","year":"2023","unstructured":"Abbe, C. & Mitchell, C. M. Bacterial vaginosis: A review of approaches to treatment and prevention. Front. Reprod. Health 5, 1100029 (2023).","journal-title":"Front. Reprod. Health"},{"key":"68443_CR13","doi-asserted-by":"crossref","unstructured":"Wu, S., Hugerth, L. W., Schuppe-Koistinen, I. & Du, J. The right bug in the right place: opportunities for bacterial vaginosis treatment. npj Biofilms Microbiomes 8, 34 (2022).","DOI":"10.1038\/s41522-022-00295-y"},{"key":"68443_CR14","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/antibiotics10080978","volume":"10","author":"A Munoz-Barreno","year":"2021","unstructured":"Munoz-Barreno, A., Cabezas-Mera, F., Tejera, E. & Machado, A. Comparative effectiveness of treatments for bacterial vaginosis: A network meta-analysis. Antibiotics 10, 978 (2021).","journal-title":"Antibiotics"},{"key":"68443_CR15","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2020.2684","volume":"323","author":"DK Owens","year":"2020","unstructured":"Owens, D. K. et al. Screening for bacterial vaginosis in pregnant persons to prevent preterm delivery: US preventive services task force recommendation statement. Jama 323, 1286\u20131292 (2020).","journal-title":"Jama"},{"key":"68443_CR16","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1093\/infdis\/jiw159","volume":"214","author":"CS Bradshaw","year":"2016","unstructured":"Bradshaw, C. S. & Sobel, J. D. Current treatment of bacterial vaginosis\u2014Limitations and need for innovation. J. Infect. Dis. 214, S14\u2013S20 (2016).","journal-title":"J. Infect. Dis."},{"key":"68443_CR17","doi-asserted-by":"publisher","first-page":"6260","DOI":"10.3390\/cancers14246260","volume":"14","author":"NA Alturki","year":"2022","unstructured":"Alturki, N. A. et al. Therapeutic target identification and inhibitor screening against riboflavin synthase of colorectal cancer associated fusobacterium nucleatum. Cancers 14, 6260 (2022).","journal-title":"Cancers"},{"key":"68443_CR18","doi-asserted-by":"publisher","DOI":"10.2174\/0115734099285473240101111303","author":"P Sinoliya","year":"2024","unstructured":"Sinoliya, P., Solanki, P. S., Niraj, R. R. K. & Sharma, V. Computational study of antimicrobial peptides for promising therapeutic applications against methicillin-resistant Staphylococcus aureus. Curr. Comput. Aided Drug Des. https:\/\/doi.org\/10.2174\/0115734099285473240101111303 (2024).","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"68443_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1389203724666221216115850","volume":"24","author":"P Sinoliya","year":"2023","unstructured":"Sinoliya, P., Solanki, P. S., Piplani, S., Kumar Niraj, R. R. & Sharma, V. Anti-microbial peptides against methicillin-resistant Staphylococcus aureus: Promising therapeutics. Curr. Protein Pept. Sci. 24, 156\u2013177. https:\/\/doi.org\/10.2174\/1389203724666221216115850 (2023).","journal-title":"Curr. Protein Pept. Sci."},{"key":"68443_CR20","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2174\/1570180817999200531165148","volume":"17","author":"SR Gupta","year":"2020","unstructured":"Gupta, S. R. et al. Comparative proteome analysis of Mycobacterium tuberculosis strains-H37Ra, H37Rv, CCDC5180, and CAS\/NITR204: A step forward to identify novel drug targets. Lett. Drug Des. Discov. 17, 1422\u20131431 (2020).","journal-title":"Lett. Drug Des. Discov."},{"key":"68443_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10930-021-10038-1","volume":"41","author":"S Zaidi","year":"2022","unstructured":"Zaidi, S., Bhardwaj, T., Somvanshi, P. & Khan, A. U. Proteomic characterization and target identification against Streptococcus mutans under bacitracin stress conditions using LC\u2013MS and subtractive proteomics. Protein J. 41, 166\u2013178 (2022).","journal-title":"Protein J."},{"key":"68443_CR22","doi-asserted-by":"publisher","first-page":"i821","DOI":"10.1093\/bioinformatics\/bty593","volume":"34","author":"H \u00d6zt\u00fcrk","year":"2018","unstructured":"\u00d6zt\u00fcrk, H., \u00d6zg\u00fcr, A. & Ozkirimli, E. DeepDTA: Deep drug-target binding affinity prediction. Bioinformatics 34, i821\u2013i829 (2018).","journal-title":"Bioinformatics"},{"key":"68443_CR23","doi-asserted-by":"crossref","unstructured":"Alzamami, A., Alturki, N. A., Khan, K., Basharat, Z. & Mashraqi, M. M. Screening inhibitors against the Ef-Tu of Fusobacterium nucleatum: A docking, ADMET and PBPK assessment study. Mol. Divers. 1\u201318 (2024).","DOI":"10.1007\/s11030-024-10815-x"},{"key":"68443_CR24","unstructured":"Korf, I., Yandell, M. & Bedell, J. Blast. (O'Reilly Media, Inc., 2003)."},{"key":"68443_CR25","doi-asserted-by":"publisher","first-page":"baaa112","DOI":"10.1093\/database\/baaa112","volume":"2020","author":"S Liu","year":"2020","unstructured":"Liu, S. et al. CEG 2.0: An updated database of clusters of essential genes including eukaryotic organisms. Database 2020, baaa112 (2020).","journal-title":"Database"},{"key":"68443_CR26","doi-asserted-by":"publisher","first-page":"D271","DOI":"10.1093\/nar\/gkh024","volume":"32","author":"R Zhang","year":"2004","unstructured":"Zhang, R., Ou, H. Y. & Zhang, C. T. DEG: A database of essential genes. Nucleic Acids Res. 32, D271\u2013D272 (2004).","journal-title":"Nucleic Acids Res."},{"key":"68443_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ygeno.2020.12.015","volume":"113","author":"Z Basharat","year":"2021","unstructured":"Basharat, Z., Jahanzaib, M., Yasmin, A. & Khan, I. A. Pan-genomics, drug candidate mining and ADMET profiling of natural product inhibitors screened against Yersinia pseudotuberculosis. Genomics 113, 238\u2013244 (2021).","journal-title":"Genomics"},{"key":"68443_CR28","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082 (2018).","journal-title":"Nucleic Acids Res."},{"key":"68443_CR29","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.3390\/ijms24065819","volume":"24","author":"D Grasso","year":"2023","unstructured":"Grasso, D., Galderisi, S., Santucci, A. & Bernini, A. Pharmacological chaperones and protein conformational diseases: Approaches of computational structural biology. Int. J. Mol. Sci. 24, 5819 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"68443_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117955","volume":"10","author":"SC Bull","year":"2015","unstructured":"Bull, S. C. & Doig, A. J. Properties of protein drug target classes. PloS one 10, e0117955 (2015).","journal-title":"PloS one"},{"key":"68443_CR31","doi-asserted-by":"crossref","unstructured":"Gasteiger, E. et al. Protein Identification and Analysis Tools on the ExPASy Server. (Humana Press, 2005).","DOI":"10.1385\/1-59259-890-0:571"},{"key":"68443_CR32","doi-asserted-by":"crossref","unstructured":"Hallgren, J. et al. DeepTMHMM predicts alpha and beta transmembrane proteins using deep neural networks. BioRxiv: 2022.2004.2008.487609 (2022).","DOI":"10.1101\/2022.04.08.487609"},{"key":"68443_CR33","first-page":"405","volume":"7","author":"S Saha","year":"2007","unstructured":"Saha, S. & Raghava, G. P. BTXpred: Prediction of bacterial toxins. In Silico Biol. 7, 405\u2013412 (2007).","journal-title":"In Silico Biol."},{"key":"68443_CR34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/bib\/bbaa294","volume":"22","author":"N Sharma","year":"2021","unstructured":"Sharma, N. et al. AlgPred 2.0: An improved method for predicting allergenic proteins and mapping of IgE epitopes. Brief. Bioinform. 22, 294 (2021).","journal-title":"Brief. Bioinform."},{"key":"68443_CR35","doi-asserted-by":"publisher","first-page":"D387","DOI":"10.1093\/nar\/gkn750","volume":"37","author":"F Kiefer","year":"2009","unstructured":"Kiefer, F., Arnold, K., K\u00fcnzli, M., Bordoli, L. & Schwede, T. The SWISS-MODEL repository and associated resources. Nucleic Acids Res. 37, D387\u2013D392 (2009).","journal-title":"Nucleic Acids Res."},{"key":"68443_CR36","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1021\/acs.jcim.2c00243","volume":"62","author":"KT B\u00e6k","year":"2022","unstructured":"B\u00e6k, K. T. & Kepp, K. P. Assessment of AlphaFold2 for human proteins via residue solvent exposure. J. Chem. Inf. Model. 62, 3391\u20133400 (2022).","journal-title":"J. Chem. Inf. Model."},{"key":"68443_CR37","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1093\/nar\/gkg520","volume":"31","author":"T Schwede","year":"2003","unstructured":"Schwede, T., Kopp, J., Guex, N. & Peitsch, M. C. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res. 31, 3381\u20133385 (2003).","journal-title":"Nucleic Acids Res."},{"key":"68443_CR38","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154046","volume":"22","author":"A Perrakis","year":"2021","unstructured":"Perrakis, A. & Sixma, T. K. AI revolutions in biology: The joys and perils of AlphaFold. EMBO Rep. 22, e54046 (2021).","journal-title":"EMBO Rep."},{"key":"68443_CR39","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita, M. et al. ColabFold: Making protein folding accessible to all. Nat. Methods 19, 679\u2013682 (2022).","journal-title":"Nat. Methods"},{"key":"68443_CR40","doi-asserted-by":"publisher","first-page":"W384","DOI":"10.1093\/nar\/gkt458","volume":"41","author":"L Heo","year":"2013","unstructured":"Heo, L., Park, H. & Seok, C. GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Res. 41, W384\u2013W388 (2013).","journal-title":"Nucleic Acids Res."},{"key":"68443_CR41","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S0968-0004(97)01140-7","volume":"22","author":"RA Laskowski","year":"1997","unstructured":"Laskowski, R. A. et al. PDBsum: A web-based database of summaries and analyses of all PDB structures. Trends Biochem. Sci. 22, 488\u2013490 (1997).","journal-title":"Trends Biochem. Sci."},{"key":"68443_CR42","doi-asserted-by":"crossref","unstructured":"Dallakyan, S. & Olson, A. J. Small-molecule library screening by docking with PyRx. Chem. Biol. Methods Protoc.  243\u2013250 (2015).","DOI":"10.1007\/978-1-4939-2269-7_19"},{"key":"68443_CR43","doi-asserted-by":"crossref","unstructured":"Sireesha, R. et al. Unveiling the anticancer mechanism of 1, 2, 3-triazole-incorporated thiazole-pyrimidine-isoxazoles: Insights from docking and molecular dynamics simulations. J. Biomol. Struct. Dyn. 1\u201313 (2023).","DOI":"10.1080\/07391102.2023.2278749"},{"key":"68443_CR44","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: Multiple ligand\u2013protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778\u20132786 (2011).","journal-title":"J. Chem. Inf. Model."},{"key":"68443_CR45","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"68443_CR46","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires, D. E., Blundell, T. L. & Ascher, D. B. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58, 4066\u20134072 (2015).","journal-title":"J. Med. Chem."},{"key":"68443_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-1-8","volume":"1","author":"P Ertl","year":"2009","unstructured":"Ertl, P. & Schuffenhauer, A. Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J. Cheminform. 1, 1\u201311 (2009).","journal-title":"J. Cheminform."},{"key":"68443_CR48","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel, D. et al. GROMACS: Fast, flexible, and free. J. Comput. Chem. 26, 1701\u20131718 (2005).","journal-title":"J. Comput. Chem."},{"key":"68443_CR49","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1021\/acs.jcim.0c01217","volume":"61","author":"Z Huai","year":"2020","unstructured":"Huai, Z., Shen, Z. & Sun, Z. Binding thermodynamics and interaction patterns of inhibitor-major urinary protein-I binding from extensive free-energy calculations: Benchmarking AMBER force fields. J. Chem. Inf. Model. 61, 284\u2013297 (2020).","journal-title":"J. Chem. Inf. Model."},{"key":"68443_CR50","doi-asserted-by":"crossref","unstructured":"Eskandari, A., Leow, T. C., Rahman, M. B. A. & Oslan, S. N. Molecular dynamics-guided insight into the adsorption\u2013inhibition mechanism for controlling ice growth\/melt of antifreeze protein type IV mutant from longhorn sculpin fish. Chem. Pap. 1\u201318 (2024).","DOI":"10.1007\/s11696-024-03407-4"},{"key":"68443_CR51","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang, E. et al. End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: Strategies and applications in drug design. Chem. Rev. 119, 9478\u20139508 (2019).","journal-title":"Chem. Rev."},{"key":"68443_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbi.2022.102219","volume":"67","author":"R Yokoyama","year":"2022","unstructured":"Yokoyama, R., Kleven, B., Gupta, A., Wang, Y. & Maeda, H. A. 3-Deoxy-D-arabino-heptulosonate 7-phosphate synthase as the gatekeeper of plant aromatic natural product biosynthesis. Curr. Opin. Plant Biol. 67, 102219 (2022).","journal-title":"Curr. Opin. Plant Biol."},{"key":"68443_CR53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11274-021-03212-1","volume":"38","author":"S Liu","year":"2022","unstructured":"Liu, S., Xu, J.-Z. & Zhang, W.-G. Advances and prospects in metabolic engineering of Escherichia coli for l-tryptophan production. World J. Microbiol. Biotechnol. 38, 22 (2022).","journal-title":"World J. Microbiol. Biotechnol."},{"key":"68443_CR54","doi-asserted-by":"crossref","unstructured":"Singh, P. et al. Biofuel from Microbes and Plants. 189\u2013209 (CRC Press, 2021).","DOI":"10.1201\/9780429262975-8"},{"key":"68443_CR55","unstructured":"Almeida, A. M. et al. Revisiting the Shikimate Pathway and Highlighting Their Enzyme Inhibitors. 1\u201337 (2023)."},{"key":"68443_CR56","unstructured":"Castro, J. I. R. Adhesion of Vaginal Microorganisms to Epithelial Cells and Its Association with Bacterial Vaginosis. (Universidade do Minho (Portugal), 2012)."},{"key":"68443_CR57","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40168-022-01317-9","volume":"10","author":"L Anton","year":"2022","unstructured":"Anton, L. et al. Gardnerella vaginalis alters cervicovaginal epithelial cell function through microbe-specific immune responses. Microbiome 10, 119 (2022).","journal-title":"Microbiome"},{"key":"68443_CR58","unstructured":"Niu, A. Toward Transition State Analysis of DAHP Synthase (2020)."},{"key":"68443_CR59","doi-asserted-by":"crossref","unstructured":"Jeckelmann, J.-M. & Erni, B. Carbohydrate transport by group translocation: the bacterial phosphoenolpyruvate: Sugar phosphotransferase system. In Bacterial Cell Walls Membranes. 223\u2013274 (2019).","DOI":"10.1007\/978-3-030-18768-2_8"},{"key":"68443_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-020-04385-6","volume":"26","author":"C Agoni","year":"2020","unstructured":"Agoni, C., Olotu, F. A., Ramharack, P. & Soliman, M. E. Druggability and drug-likeness concepts in drug design: Are biomodelling and predictive tools having their say?. J. Mol. Model. 26, 1\u201311 (2020).","journal-title":"J. Mol. Model."},{"key":"68443_CR61","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00284-022-02771-2","volume":"79","author":"E Amabebe","year":"2022","unstructured":"Amabebe, E. & Anumba, D. O. Mechanistic insights into immune suppression and evasion in bacterial vaginosis. Curr. Microbiol. 79, 84 (2022).","journal-title":"Curr. Microbiol."},{"key":"68443_CR62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.placenta.2022.02.018","volume":"120","author":"YP Wong","year":"2022","unstructured":"Wong, Y. P. et al. Gardnerella vaginalis infection in pregnancy: Effects on placental development and neonatal outcomes. Placenta 120, 79\u201387 (2022).","journal-title":"Placenta"},{"key":"68443_CR63","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/children10050907","volume":"10","author":"G Daskalakis","year":"2023","unstructured":"Daskalakis, G. et al. Maternal infection and preterm birth: from molecular basis to clinical implications. Children 10, 907 (2023).","journal-title":"Children"},{"key":"68443_CR64","doi-asserted-by":"crossref","unstructured":"Menard, J.-P. Antibacterial treatment of bacterial vaginosis: Current and emerging therapies. Int. J. Women's Health 295\u2013305 (2011).","DOI":"10.2147\/IJWH.S23814"},{"key":"68443_CR65","first-page":"2125","volume":"70","author":"MK Owen","year":"2004","unstructured":"Owen, M. K. & Clenney, T. L. Management of vaginitis. Am. Fam. Phys. 70, 2125\u20132132 (2004).","journal-title":"Am. Fam. Phys."},{"key":"68443_CR66","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s43032-019-00048-x","volume":"27","author":"H Pentikis","year":"2020","unstructured":"Pentikis, H., Adetoro, N., Tipping, D. & Levy, S. An integrated efficacy and safety analysis of single-dose secnidazole 2 g in the treatment of bacterial vaginosis. Reprod. Sci. 27, 523\u2013528 (2020).","journal-title":"Reprod. Sci."},{"key":"68443_CR67","doi-asserted-by":"publisher","first-page":"34","DOI":"10.13057\/biodiv\/d230608","volume":"23","author":"IAA Al-Kraety","year":"2022","unstructured":"Al-Kraety, I. A. A., Al-Muhanna, S. G., Banoon, S. R. & Ghasemian, A. Bacterial vaginosis pattern and antibiotic susceptibility testing in female patients using high vaginal swabs. Biodivers. J. Biol. Divers. 23, 34 (2022).","journal-title":"Biodivers. J. Biol. Divers."},{"key":"68443_CR68","doi-asserted-by":"crossref","unstructured":"Qian, Z., Zhao, D., Yin, Y., Zhu, H. & Chen, D. Antibacterial activity of Lactobacillus strains isolated from Mongolian yogurt against Gardnerella vaginalis. BioMed Res. Int. 2020 (2020).","DOI":"10.1155\/2020\/3548618"},{"key":"68443_CR69","unstructured":"Ahmad, S. S. & Ali, F. A. Detection of ESBL, AmpC and metallo beta-lactamase mediated resistance in Gram-negative bacteria isolated from women with genital tract infection. Eur. Sci. J. 10 (2014)."},{"key":"68443_CR70","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/biology11010086","volume":"11","author":"S Wang","year":"2022","unstructured":"Wang, S., Liu, D., Bilal, M., Wang, W. & Zhang, X. Uncovering the role of phzc as DAHP synthase in shikimate pathway of Pseudomonas chlororaphis HT66. Biology 11, 86 (2022).","journal-title":"Biology"},{"key":"68443_CR71","doi-asserted-by":"crossref","unstructured":"Tohge, T. & R Fernie, A. An overview of compounds derived from the shikimate and phenylpropanoid pathways and their medicinal importance. Mini Rev. Med. Chem. 17, 1013\u20131027 (2017).","DOI":"10.2174\/1389557516666160624123425"},{"key":"68443_CR72","unstructured":"Almeida, A. M. et al. Revisiting the shikimate pathway and highlighting their enzyme inhibitors. Phytochem. Rev. 1\u201337 (2023)."},{"key":"68443_CR73","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2174\/157489312803900983","volume":"7","author":"A Dev","year":"2012","unstructured":"Dev, A., Tapas, S., Pratap, S. & Kumar, P. Structure and function of enzymes of shikimate pathway. Curr. Bioinform. 7, 374\u2013391 (2012).","journal-title":"Curr. Bioinform."},{"key":"68443_CR74","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jmb.2004.05.077","volume":"341","author":"IA Shumilin","year":"2004","unstructured":"Shumilin, I. A., Bauerle, R., Wu, J., Woodard, R. W. & Kretsinger, R. H. Crystal structure of the reaction complex of 3-deoxy-d-arabino-heptulosonate-7-phosphate synthase from Thermotoga maritima refines the catalytic mechanism and indicates a new mechanism of allosteric regulation. J. Mol. Biol. 341, 455\u2013466 (2004).","journal-title":"J. Mol. Biol."},{"key":"68443_CR75","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jsb.2019.04.001","volume":"206","author":"D Cui","year":"2019","unstructured":"Cui, D. et al. Molecular basis for feedback inhibition of tyrosine-regulated 3-deoxy-d-arabino-heptulosonate-7-phosphate synthase from Escherichia coli. J. Struct. Biol. 206, 322\u2013334 (2019).","journal-title":"J. Struct. Biol."},{"key":"68443_CR76","doi-asserted-by":"publisher","first-page":"6617","DOI":"10.1021\/acs.biochem.6b00930","volume":"55","author":"N Balachandran","year":"2016","unstructured":"Balachandran, N. et al. Potent inhibition of 3-deoxy-d-arabinoheptulosonate-7-phosphate (DAHP) synthase by DAHP oxime, a phosphate group mimic. Biochemistry 55, 6617\u20136629 (2016).","journal-title":"Biochemistry"},{"key":"68443_CR77","doi-asserted-by":"publisher","first-page":"107735","DOI":"10.1016\/j.jmgm.2020.107735","volume":"101","author":"MD de Oliveira","year":"2020","unstructured":"de Oliveira, M. D., Araujo, J. D. O., Gal\u00facio, J. M., Santana, K. & Lima, A. H. Targeting shikimate pathway: In silico analysis of phosphoenolpyruvate derivatives as inhibitors of EPSP synthase and DAHP synthase. J. Mol. Graph. Model. 101, 107735 (2020).","journal-title":"J. Mol. Graph. Model."},{"key":"68443_CR78","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ejps.2007.05.110","volume":"31","author":"S Stegemann","year":"2007","unstructured":"Stegemann, S., Leveiller, F., Franchi, D., De Jong, H. & Lind\u00e9n, H. When poor solubility becomes an issue: From early stage to proof of concept. Eur. J. Pharmaceut. Sci. 31, 249\u2013261 (2007).","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"68443_CR79","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1517\/17460441.2012.715631","volume":"7","author":"Y Fang","year":"2012","unstructured":"Fang, Y. Ligand\u2013receptor interaction platforms and their applications for drug discovery. Exp. Opin. Drug Discov. 7, 969\u2013988 (2012).","journal-title":"Exp. Opin. Drug Discov."},{"key":"68443_CR80","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.foodchem.2016.11.124","volume":"221","author":"J He","year":"2017","unstructured":"He, J. et al. Binding properties of the natural red dye carthamin with human serum albumin: Surface plasmon resonance, isothermal titration microcalorimetry, and molecular docking analysis. Food Chem. 221, 650\u2013656 (2017).","journal-title":"Food Chem."},{"key":"68443_CR81","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/17460441.2019.1623202","volume":"14","author":"V Kairys","year":"2019","unstructured":"Kairys, V., Baranauskiene, L., Kazlauskiene, M., Matulis, D. & Kazlauskas, E. Binding affinity in drug design: Experimental and computational techniques. Expert Opin Drug Discov. 14, 755\u2013768 (2019).","journal-title":"Expert Opin Drug Discov."},{"key":"68443_CR82","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2174\/1389200221999210101233340","volume":"22","author":"KS Taskar","year":"2021","unstructured":"Taskar, K. S., Harada, I. & Alluri, R. V. Physiologically-based pharmacokinetic (PBPK) modelling of transporter mediated drug absorption, clearance and drug\u2013drug interactions. Curr. Drug Metab. 22, 523\u2013531 (2021).","journal-title":"Curr. Drug Metab."},{"key":"68443_CR83","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s40262-022-01169-4","volume":"61","author":"S Alrubia","year":"2022","unstructured":"Alrubia, S., Mao, J., Chen, Y., Barber, J. & Rostami-Hodjegan, A. Altered bioavailability and pharmacokinetics in Crohn\u2019s disease: Capturing systems parameters for PBPK to assist with predicting the fate of orally administered drugs. Clin. Pharmacokinet. 61, 1365\u20131392 (2022).","journal-title":"Clin. Pharmacokinet."},{"key":"68443_CR84","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10928-016-9492-y","volume":"43","author":"C Hartmanshenn","year":"2016","unstructured":"Hartmanshenn, C., Scherholz, M. & Androulakis, I. P. Physiologically-based pharmacokinetic models: Approaches for enabling personalized medicine. J. Pharmacokinet. Pharmacodyn. 43, 481\u2013504 (2016).","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"68443_CR85","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1586\/ecp.10.143","volume":"4","author":"K Rowland Yeo","year":"2011","unstructured":"Rowland Yeo, K., Aarabi, M., Jamei, M. & Rostami-Hodjegan, A. Modeling and predicting drug pharmacokinetics in patients with renal impairment. Expert Rev. Clin. Pharmacol. 4, 261\u2013274 (2011).","journal-title":"Expert Rev. Clin. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68443-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68443-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68443-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T14:17:14Z","timestamp":1722262634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68443-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["68443"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-68443-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Chenyue Fan, Karmen Mah, and Calvin R. Wei are employed by Shing Huei Group. Zarrin Basharat is employed by Alpha Genomics Private Limited.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17437"}}